Sanofi and BioMap entered a strategic collaboration to co-develop AI modules accelerating biotherapeutic drug discovery using BioMap's protein large language model. BioMap received $10M upfront plus near-term model development payments, with R&D/sales milestones across products totaling over $1B. Top-25 buyer inclusion.
Key facts
AnnouncedOct 10, 2023
Deal value$1.0B
Deal typeCo-Development
Therapeutic areaMultiple — biologics discovery across therapeutic areas
IndicationsMultiple — biologics discovery across therapeutic areas
Key assetsAI modules for biotherapeutic drug discovery (foundation model platform)